Abstract
Although sex differences in brain function and brain disorders are well documented, very few studies have had adequate number of women to address sex-related factors contributing to HIV-associated brain dysfunction. Compared to men living with HIV (MLWH), women living with HIV (WLWH) may be at greater risk for cognitive dysfunction and decline due to biological factors (e.g., hormonal, immunologic) and issues common in underserved communities including poverty, low literacy levels, mental health and substance abuse, barriers to health-care services, and environmental exposures. To address this issue, we review relevant cross-sectional and longitudinal findings from the Women’s Interagency HIV Study (WIHS), the largest study of the natural and treated history of WLWH, as well as other studies focusing on cognitive complications of HIV in women. We provide evidence that WLWH are more cognitively vulnerable than MLWH and that there are differences in the pattern of cognitive impairment. We next discuss factors that contribute to these differences, including biological factors (e.g., inflammation, hormonal, genetic) as well as common comorbidities (mental health, substance use, vascular and metabolic risk factors, coinfections and liver function, non-antiretroviral medications, and genetic markers). These findings demonstrate the importance of considering sex as a biological factor in studies of cognitive dysfunction and suggest avenues for future research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baker JT, Sanders AL, Maccotta L, Buckner RL (2001) Neural correlates of verbal memory encoding during semantic and structural processing tasks. Neuroreport 12:1251–1256
Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, Miotti P, Young M, Greenblatt R, Sacks H, Feldman J (1998) The Women’s Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 9:117–125
Becker S, Lim J (2003) A computational model of prefrontal control in free recall: strategic memory use in the California Verbal Learning Task. J Cogn Neurosci 15:821–832
Behrman-Lay AM, Paul RH, Heaps-Woodruff J, Baker LM, Usher C, Ances BM (2016) Human immunodeficiency virus has similar effects on brain volumetrics and cognition in males and females. J Neurovirol 22:93–103
Bull L, Tittle V, Rashid T, Nwokolo N (2018) HIV and the menopause: a review. Post Reprod Health 24:19–25
Burdo TH, Weiffenbach A, Woods SP, Letendre S, Ellis RJ, Williams KC (2013) Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection. AIDS 27:1387–1395
Burlacu R, Umlauf A, Luca A, Gianella S, Radoi R, Ruta SM, Marcotte TD, Ene L, Achim CL (2018) Sex-based differences in neurocognitive functioning in HIV-infected young adults. AIDS 32:217–225
Cahill L (2006) Why sex matters for neuroscience. Nat Rev Neurosci 7:477–484
Carey CL, Woods SP, Rippeth JD, Gonzalez R, Heaton RK, Grant I (2006) Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection. AIDS Behav 10:185–190
Centers for Disease Control and Prevention (2017) Monitoring selected national HIV prevention and care objectives by using HIV surveillance data – United States and 6 dependent areas, 2015. HIV Surveill Suppl Rep 22(2)
Cohen RA, Boland R, Paul R, Tashima KT, Schoenbaum EE, Celentano DD, Schuman P, Smith DK, Carpenter CC (2001) Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. AIDS 15:341–345
Colon K, Perez-Laspiur J, Quiles R, Rodriguez Y, Wojna V, Shaffer SA, Leszyk J, Skolasky RL Jr, Melendez LM (2016) Macrophage secretome from women with HIV-associated neurocognitive disorders. Proteomics Clin Appl 10:136–143
Crystal H, Kleyman I, Anastos K, Lazar J, Cohen M, Liu C, Pearce L, Golub E, Valcour V, Ho A, Strickler H, Peters M, Kovacs A, Holman S, Kreek MJ, Manly J (2012) Effects of hepatitis C and HIV on cognition in women: data from The Women’s Interagency HIV Study. J Acquir Immune Defic Syndr 59:149–154
Cysique LA, Maruff P, Brew BJ (2004) Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. J Neurovirol 10:350–357
Cysique LA, Heaton RK, Kamminga J, Lane T, Gates TM, Moore DM, Hubner E, Carr A, Brew BJ (2014) HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuro HIV research. J Neurovirol 20:258–268
Durvasula RS, Miller EN, Myers HF, Wyatt GE (2001) Predictors of neuropsychological performance in HIV positive women. J Clin Exp Neuropsychol 23:149–163
Failde-Garrido JM, Alvarez MR, Simon-Lopez MA (2008) Neuropsychological impairment and gender differences in HIV-1 infection. Psychiatry Clin Neurosci 62:494–502
Fogel J, Rubin LH, Maki P, Keutmann MK, Gonzalez R, Vassileva J, Martin EM (2017) Effects of sex and HIV serostatus on spatial navigational learning and memory among cocaine users. J Neurovirol 23:855–863
Gerena Y, Skolasky RL, Velez JM, Toro-Nieves D, Mayo R, Nath A, Wojna V (2012) Soluble and cell-associated insulin receptor dysfunction correlates with severity of HAND in HIV-infected women. PLoS One 7:e37358
Gerena Y, Menendez-Delmestre R, Skolasky RL, Hechavarria RM, Perez S, Hilera C, Gonzalez C, Nath A, Wojna V (2015) Soluble insulin receptor as a source of insulin resistance and cognitive impairment in HIV-seropositive women. J Neurovirol 21:113–119
Giesbrecht CJ, Thornton AE, Hall-Patch C, Maan EJ, Cote HC, Money DM, Murray M, Pick N (2014) Select neurocognitive impairment in HIV-infected women: associations with HIV viral load, hepatitis C virus, and depression, but not leukocyte telomere length. PLoS One 9:e89556
Grant I (2008) Neurocognitive disturbances in HIV. Int Rev Psychiatry 20:33–47
Gustafson DR, Mielke MM, Tien PC, Valcour V, Cohen M, Anastos K, Liu C, Pearce L, Golub ET, Minkoff H, Crystal HA (2013) Anthropometric measures and cognition in middle-aged HIV-infected and uninfected women. The Women’s Interagency HIV Study. J Neurovirol 19:574–585
Gustafson DR, Mielke MM, Keating SA, Holman S, Minkoff H, Crystal HA (2015) Leptin, adiponectin and cognition in middle-aged HIV-infected and uninfected women. The Brooklyn Women’s Interagency HIV Study. J Gerontol Geriatr Res 4(5). pii: 240
Heaton RK, Franklin DR, Ellis RJ, Mccutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, Mcarthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17:3–16
Heaton RK, Franklin DR Jr, Deutsch R, Letendre S, Ellis RJ, Casaletto K, Marquine MJ, Woods SP, Vaida F, Atkinson JH, Marcotte TD, Mccutchan JA, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Morgello S, Simpson DM, Abramson I, Gamst AC, Fennema-Notestine C, Smith DM, Grant I, CHARTER Group (2015) Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis 60:473–480
Hestad KA, Menon JA, Silalukey-Ngoma M, Franklin DR Jr, Imasiku ML, Kalima K, Heaton RK (2012) Sex differences in neuropsychological performance as an effect of human immunodeficiency virus infection: a pilot study in Zambia, Africa. J Nerv Ment Dis 200:336–342
Huck DM, Hanna DB, Rubin LH, Maki P, Valcour V, Springer G, Xue X, Lazar J, Hodis HN, Anastos K, Kaplan RC, Kizer JR (2018) Carotid artery stiffness and cognitive decline among women with or at risk for HIV infection. J Acquir Immune Defic Syndr 78:338–347
Imp BM, Rubin LH, Tien PC, Plankey MW, Golub ET, French AL, Valcour VG (2017) Monocyte activation is associated with worse cognitive performance in HIV-infected women with virologic suppression. J Infect Dis 215:114–121
Keutmann MK, Gonzalez R, Maki PM, Rubin LH, Vassileva J, Martin EM (2016) Sex differences in HIV effects on visual memory among substance-dependent individuals. J Clin Exp Neuropsychol:1–13
Maki PM, Martin-Thormeyer E (2009) HIV, cognition and women. Neuropsychol Rev 19:204–214
Maki PM, Cohen MH, Weber K, Little DM, Fornelli D, Rubin LH, Perschler P, Gould F, Martin E (2009) Impairments in memory and hippocampal function in HIV-positive vs HIV-negative women: a preliminary study. Neurology 72:1661–1668
Maki PM, Rubin LH, Valcour V, Martin E, Crystal H, Young M, Weber KM, Manly J, Richardson J, Alden C, Anastos K (2015) Cognitive function in women with HIV: findings from the Women’s Interagency HIV Study. Neurology 84:231–240
Maki PM, Rubin LH, Springer G, Seaberg EC, Sacktor N, Miller EN, Valcour V, Young MA, Becker JT, Martin EM, Neuropsychology Working Groups of the Womenʼs Interagency HIV Study and the Multicenter AIDS Cohort Study (2018) Differences in cognitive function between women and men with HIV. J Acquir Immune Defic Syndr 79:101–107
Martin E, Gonzalez R, Vassileva J, Maki PM, Bechara A, Brand M (2016) Sex and HIV serostatus differences in decision making under risk among substance-dependent individuals. J Clin Exp Neuropsychol 38:404–415
Mason KI, Campbell A, Hawkins P, Madhere S, Johnson K, Takushi-Chinen R (1998) Neuropsychological functioning in HIV-positive African-American women with a history of drug use. J Natl Med Assoc 90:665–674
Mcfarlane SI, Mielke MM, Uglialoro A, Keating SM, Holman S, Minkoff H, Crystal HA, Gustafson DR (2017) Ghrelin, amylin, gastric inhibitory peptide and cognition in middle-aged HIV-infected and uninfected women: The Women's Interagency HIV Study. J Neurol Neurophysiol 8(1). pii: 413
Meyer VJ, Rubin LH, Martin E, Weber KM, Cohen MH, Golub ET, Valcour V, Young MA, Crystal H, Anastos K, Aouizerat BE, Milam J, Maki PM (2013) HIV and recent illicit drug use interact to affect verbal memory in women. J Acquir Immune Defic Syndr 63:67–76
Meyer VJ, Little DM, Fitzgerald DA, Sundermann EE, Rubin LH, Martin EM, Weber KM, Cohen MH, Maki PM (2014) Crack cocaine use impairs anterior cingulate and prefrontal cortex function in women with HIV infection. J Neurovirol 20:352–361
Morales D, Acevedo SF, Skolasky RL, Hechavarria R, Santiago S, De La Torre T, Maldonado E, Wojna V (2012) Translational spatial task and its relationship to HIV-associated neurocognitive disorders and apolipoprotein E in HIV-seropositive women. J Neurovirol 18:488–502
Morgan EE, Woods SP, Letendre SL, Franklin DR, Bloss C, Goate A, Heaton RK, Collier AC, Marra CM, Gelman BB, Mcarthur JC, Morgello S, Simpson DM, Mccutchan JA, Ellis RJ, Abramson I, Gamst A, Fennema-Notestine C, Smith DM, Grant I, Vaida F, Clifford DB, CNS HIV Antiretroviral Therapy Effects Research (CHARTER) Group (2013) Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders. J Neurovirol 19:150–156
Nath A, Maragos WF, Avison MJ, Schmitt FA, Berger JR (2001) Acceleration of HIV dementia with methamphetamine and cocaine. J Neurovirol 7:66–71
Norman MA, Moore DJ, Taylor M, Franklin D Jr, Cysique L, Ake C, Lazarretto D, Vaida F, Heaton RK (2011) Demographically corrected norms for African Americans and Caucasians on the Hopkins verbal learning test-revised, brief visuospatial memory test-revised, stroop color and word test, and wisconsin card sorting test 64-card version. J Clin Exp Neuropsychol 33:793–804
Radtke KK, Bacchetti P, Anastos K, Merenstein D, Crystal H, Karim R, Weber KM, Edmonds A, Sheth AN, Fischl MA, Vance D, Greenblatt RM, Rubin LH (2018) Use of nonantiretroviral medications that may impact neurocognition: patterns and predictors in a large, long-term HIV cohort study. J Acquir Immune Defic Syndr 78:202–208
Richardson JL, Martin EM, Jimenez N, Danley K, Cohen M, Carson VL, Sinclair B, Racenstein JM, Reed RA, Levine AM (2002) Neuropsychological functioning in a cohort of HIV infected women: importance of antiretroviral therapy. J Int Neuropsychol Soc 8:781–793
Richardson JL, Nowicki M, Danley K, Martin EM, Cohen MH, Gonzalez R, Vassileva J, Levine AM (2005) Neuropsychological functioning in a cohort of HIV− and hepatitis C virus-infected women. AIDS 19:1659–1667
Robertson K, Fiscus S, Wilkins J, van der Horst C, Hall C (1996) Viral load and neuropsychological functioning in HIV seropositive individuals: a preliminary descriptive study. J Neuro AIDS 1:7–15
Robertson K, Bayon C, Molina JM, Mcnamara P, Resch C, Munoz-Moreno JA, Kulasegaram R, Schewe K, Burgos-Ramirez A, De Alvaro C, Cabrero E, Guion M, Norton M, Van Wyk J (2014) Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada. AIDS Care 26:1555–1561
Royal W 3rd, Cherner M, Burdo TH, Umlauf A, Letendre SL, Jumare J, Abimiku A, Alabi P, Alkali N, Bwala S, Okwuasaba K, Eyzaguirre LM, Akolo C, Guo M, Williams KC, Blattner WA (2016) Associations between cognition, gender and monocyte activation among HIV infected individuals in Nigeria. PLoS One 11:e0147182
Rubin LH, Sundermann EE, Cook JA, Martin EM, Golub ET, Weber KM, Cohen MH, Crystal H, Cederbaum JA, Anastos K, Young M, Greenblatt RM, Maki PM (2014) Investigation of menopausal stage and symptoms on cognition in human immunodeficiency virus-infected women. Menopause 21(9):997–1006
Rubin LH, Cook JA, Weber KM, Cohen MH, Martin E, Valcour V, Milam J, Anastos K, Young MA, Alden C, Gustafson DR, Maki PM (2015a) The association of perceived stress and verbal memory is greater in HIV-infected versus HIV-uninfected women. J Neurovirol 21:422–432
Rubin LH, Meyer VJ, Conant R, Sundermann EE, Wu M, Weber KM, Cohen MH, Little DM, Maki PM (2015b) Prefrontal cortical volume loss is associated with stress-related deficits in verbal learning and memory in HIV-infected women. Neurobiol Dis 92(Pt B):166–174
Rubin LH, Pyra M, Cook JA, Weber KM, Cohen MH, Martin E, Valcour V, Milam J, Anastos K, Young MA, Alden C, Gustafson DR, Maki PM (2016a) Post-traumatic stress is associated with verbal learning, memory, and psychomotor speed in HIV-infected and HIV-uninfected women. J Neurovirol 22:159–169
Rubin LH, Wu M, Sundermann EE, Meyer VJ, Smith R, Weber KM, Cohen MH, Little DM, Maki PM (2016b) Elevated stress is associated with prefrontal cortex dysfunction during a verbal memory task in women with HIV. J Neurovirol 22(6):840–851
Rubin LH, Wu M, Sundermann EE, Meyer VJ, Smith R, Weber KM, Cohen MH, Little DM, Maki PM (2016c) Elevated stress is associated with prefrontal cortex dysfunction during a verbal memory task in women with HIV. J Neurovirol 22(6):840–851
Rubin LH, Benning L, Keating SM, Norris PJ, Burke-Miller J, Savarese A, Kumanan KN, Awadalla S, Springer G, Anastos K, Young M, Milam J, Valcour VG, Weber KM, Maki PM (2017a) Variability in C-reactive protein is associated with cognitive impairment in women living with and without HIV: a longitudinal study. J Neurovirol 24(1):41–51
Rubin LH, Cook JA, Springer G, Weber KM, Cohen MH, Martin EM, Valcour VG, Benning L, Alden C, Milam J, Anastos K, Young MA, Gustafson DR, Sundermann EE, Maki PM (2017b) Perceived and post-traumatic stress are associated with decreased learning, memory, and fluency in HIV-infected women. AIDS 31:2393–1401
Rubin LH, Maki PM, Springer G, Benning L, Anastos K, Gustafson D, Villacres MC, Jiang X, Adimora AA, Waldrop-Valverde D, Vance DE, Bolivar H, Alden C, Martin EM, Valcour VG, Women’s Interagency HIV Study (2017c) Cognitive trajectories over 4 years among HIV-infected women with optimal viral suppression. Neurology 89:1594–1603
Rubin LH, Phan KL, Keating SM, Weber KM, Maki PM (2017d) Brief report: low-dose hydrocortisone has acute enhancing effects on verbal learning in HIV-infected men. J Acquir Immune Defic Syndr 75:e65–e70
Rubin LH, Phan KL, Keating SM, Maki PM (2018a) A single low-dose of hydrocortisone enhances cognitive functioning in HIV-infected women. AIDS 32:1983–1993
Rubin LH, Radtke KK, Eum S, Tamraz B, Kumanan KN, Springer G, Maki PM, Anastos K, Merenstein D, Karim R, Weber KM, Gustafson D, Greenblatt RM, Bishop JR (2018b) Cognitive burden of common non-antiretroviral medications in HIV-infected women. J Acquir Immune Defic Syndr 79(1):83–91
Spies G, Fennema-Notestine C, Cherner M, Seedat S (2017) Changes in cognitive function in women with HIV infection and early life stress. AIDS Care 29:14–23
Stern RA, Arruda JE, Somerville JA, Cohen RA, Boland RJ, Stein MD, Martin EM (1998) Neurobehavioral functioning in asymptomatic HIV-1 infected women. J Int Neuropsychol Soc 4:172–178
Sundermann EE, Bishop JR, Rubin LH, Little DM, Meyer VJ, Martin E, Weber K, Cohen M, Maki PM (2015) Genetic predictor of working memory and prefrontal function in women with HIV. J Neurovirol 21:81–91
Sundermann EE, Heaton RK, Pasipanodya E, Moore RC, Paolillo EW, Rubin LH, Ellis R, Moore DJ, HNRP Group (2018) Sex differences in HIV-associated cognitive impairment. AIDS 32:2719–2726
UN Women (2018) Facts and figures: HIV and AIDS [Online]. http://www.unwomen.org/en/what-we-do/hiv-and-aids/facts-and-figures#notes. Accessed 15 Aug 2018
Valcour V, Shikuma C, Shiramizu B, Watters M, Poff P, Selnes OA, Grove J, Liu Y, Abdul-Majid KB, Gartner S, Sacktor N (2004) Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort. J Neuroimmunol 157:197–202
Valcour V, Maki P, Bacchetti P, Anastos K, Crystal H, Young M, Mack WJ, Cohen M, Golub ET, Tien PC (2012) Insulin resistance and cognition among HIV-infected and HIV-uninfected adult women: the Women’s Interagency HIV Study. AIDS Res Hum Retroviruses 28:447–453
Valcour V, Rubin LH, Tien P, Anastos K, Young M, Mack W, Cohen M, Golub ET, Crystal H, Maki PM (2015) Human immunodeficiency virus (HIV) modulates the associations between insulin resistance and cognition in the current combination antiretroviral therapy (cART) era: a study of the Women’s Interagency HIV Study (WIHS). J Neurovirol 21:415–421
Valcour VG, Rubin LH, Obasi MU, Maki PM, Peters MG, Levin S, Crystal HA, Young MA, Mack WJ, Cohen MH, Pierce CB, Adimora AA, Tien PC (2016) Liver fibrosis linked to cognitive performance in HIV and hepatitis C. J Acquir Immune Defic Syndr 72(3):266–273
Wendelken LA, Jahanshad N, Rosen HJ, Busovaca E, Allen I, Coppola G, Adams C, Rankin KP, Milanini B, Clifford K, Wojta K, Nir TM, Gutman BA, Thompson PM, Valcour V (2016) ApoE epsilon4 is associated with cognition, brain integrity, and atrophy in HIV over age 60. J Acquir Immune Defic Syndr 73:426–432
Wojna V, Skolasky RL, Hechavarria R, Mayo R, Selnes O, Mcarthur JC, Melendez LM, Maldonado E, Zorrilla CD, Garcia H, Kraiselburd E, Nath A (2006) Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment. J Neurovirol 12:356–364
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rubin, L.H., Maki, P.M. (2019). Neurocognitive Complications of HIV Infection in Women: Insights from the WIHS Cohort. In: Cysique, L.A., Rourke, S.B. (eds) Neurocognitive Complications of HIV-Infection. Current Topics in Behavioral Neurosciences, vol 50. Springer, Cham. https://doi.org/10.1007/7854_2019_101
Download citation
DOI: https://doi.org/10.1007/7854_2019_101
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-80758-0
Online ISBN: 978-3-030-80759-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)